Literature DB >> 14610279

Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7/BUS breast cancer cells by DNA microarray.

Kathryn R Coser1, Jessica Chesnes, Jingyung Hur, Sandip Ray, Kurt J Isselbacher, Toshi Shioda.   

Abstract

To obtain comprehensive information on 17beta-estradiol (E2) sensitivity of genes that are inducible or suppressible by this hormone, we designed a method that determines ligand sensitivities of large numbers of genes by using DNA microarray and a set of simple Perl computer scripts implementing the standard metric statistics. We used it to characterize effects of low (0-100 pM) concentrations of E2 on the transcriptome profile of MCF7/BUS human breast cancer cells, whose E2 dose-dependent growth curve saturated with 100 pM E2. Evaluation of changes in mRNA expression for all genes covered by the DNA microarray indicated that, at a very low concentration (10 pM), E2 suppressed approximately 3-5 times larger numbers of genes than it induced, whereas at higher concentrations (30-100 pM) it induced approximately 1.5-2 times more genes than it suppressed. Using clearly defined statistical criteria, E2-inducible genes were categorized into several classes based on their E2 sensitivities. This approach of hormone sensitivity analysis revealed that expression of two previously reported E2-inducible autocrine growth factors, transforming growth factor alpha and stromal cell-derived factor 1, was not affected by 100 pM and lower concentrations of E2 but strongly enhanced by 10 nM E2, which was far higher than the concentration that saturated the E2 dose-dependent growth curve of MCF7/BUS cells. These observations suggested that biological actions of E2 are derived from expression of multiple genes whose E2 sensitivities differ significantly and, hence, depend on the E2 concentration, especially when it is lower than the saturating level, emphasizing the importance of characterizing the ligand dose-dependent aspects of E2 actions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14610279      PMCID: PMC283534          DOI: 10.1073/pnas.2235866100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  The Bioperl toolkit: Perl modules for the life sciences.

Authors:  Jason E Stajich; David Block; Kris Boulez; Steven E Brenner; Stephen A Chervitz; Chris Dagdigian; Georg Fuellen; James G R Gilbert; Ian Korf; Hilmar Lapp; Heikki Lehväslaiho; Chad Matsalla; Chris J Mungall; Brian I Osborne; Matthew R Pocock; Peter Schattner; Martin Senger; Lincoln D Stein; Elia Stupka; Mark D Wilkinson; Ewan Birney
Journal:  Genome Res       Date:  2002-10       Impact factor: 9.043

2.  Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions.

Authors:  W Wang; L Dong; B Saville; S Safe
Journal:  Mol Endocrinol       Date:  1999-08

3.  Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

Authors:  Y Shang; X Hu; J DiRenzo; M A Lazar; M Brown
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

Review 4.  Estrogen receptor interaction with estrogen response elements.

Authors:  C M Klinge
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

5.  Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology.

Authors:  Ali Pedram; Mahnaz Razandi; Mark Aitkenhead; Christopher C W Hughes; Ellis R Levin
Journal:  J Biol Chem       Date:  2002-10-07       Impact factor: 5.157

6.  Development of cDNA microarray for expression profiling of estrogen-responsive genes.

Authors:  A Inoue; N Yoshida; Y Omoto; S Oguchi; T Yamori; R Kiyama; S Hayashi
Journal:  J Mol Endocrinol       Date:  2002-10       Impact factor: 5.098

7.  Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.

Authors:  O W Prall; B Sarcevic; E A Musgrove; C K Watts; R L Sutherland
Journal:  J Biol Chem       Date:  1997-04-18       Impact factor: 5.157

8.  Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein.

Authors:  T Yahata; W Shao; H Endoh; J Hur; K R Coser; H Sun; Y Ueda; S Kato; K J Isselbacher; M Brown; T Shioda
Journal:  Genes Dev       Date:  2001-10-01       Impact factor: 11.361

9.  Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells.

Authors:  M H Jeng; M A Shupnik; T P Bender; E H Westin; D Bandyopadhyay; R Kumar; S Masamura; R J Santen
Journal:  Endocrinology       Date:  1998-10       Impact factor: 4.736

10.  Activation of the MAPK pathway enhances sensitivity of MCF-7 breast cancer cells to the mitogenic effect of estradiol.

Authors:  Wei Yue; Ji-Ping Wang; Mark Conaway; Shigeru Masamura; Yuebai Li; Richard J Santen
Journal:  Endocrinology       Date:  2002-09       Impact factor: 4.736

View more
  70 in total

1.  Masculine epigenetic sex marks of the CYP19A1/aromatase promoter in genetically male chicken embryonic gonads are resistant to estrogen-induced phenotypic sex conversion.

Authors:  Haley L Ellis; Keiko Shioda; Noël F Rosenthal; Kathryn R Coser; Toshi Shioda
Journal:  Biol Reprod       Date:  2012-07-26       Impact factor: 4.285

Review 2.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.

Authors:  Laura N Vandenberg; Theo Colborn; Tyrone B Hayes; Jerrold J Heindel; David R Jacobs; Duk-Hee Lee; Toshi Shioda; Ana M Soto; Frederick S vom Saal; Wade V Welshons; R Thomas Zoeller; John Peterson Myers
Journal:  Endocr Rev       Date:  2012-03-14       Impact factor: 19.871

Review 3.  Epigenetic effects of endocrine-disrupting chemicals on female reproduction: an ovarian perspective.

Authors:  Aparna Mahakali Zama; Mehmet Uzumcu
Journal:  Front Neuroendocrinol       Date:  2010-07-04       Impact factor: 8.606

4.  Importance of dosage standardization for interpreting transcriptomal signature profiles: evidence from studies of xenoestrogens.

Authors:  Toshi Shioda; Jessica Chesnes; Kathryn R Coser; Lihua Zou; Jingyung Hur; Kathleen L Dean; Carlos Sonnenschein; Ana M Soto; Kurt J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-01       Impact factor: 11.205

5.  Expressomal approach for comprehensive analysis and visualization of ligand sensitivities of xenoestrogen responsive genes.

Authors:  Toshi Shioda; Noël F Rosenthal; Kathryn R Coser; Mizuki Suto; Mukta Phatak; Mario Medvedovic; Vincent J Carey; Kurt J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-23       Impact factor: 11.205

6.  Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.

Authors:  C Elizabeth Caldon; C Marcelo Sergio; Judith Schütte; Marijke N Boersma; Robert L Sutherland; Jason S Carroll; Elizabeth A Musgrove
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

7.  ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification.

Authors:  June X Zou; Alexey S Revenko; Li B Li; Abigael T Gemo; Hong-Wu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-12       Impact factor: 11.205

8.  Role of SP transcription factors in hormone-dependent modulation of genes in MCF-7 breast cancer cells: microarray and RNA interference studies.

Authors:  Fei Wu; Ivan Ivanov; Rui Xu; Stephen Safe
Journal:  J Mol Endocrinol       Date:  2008-10-24       Impact factor: 5.098

9.  Linking Notch signaling to ischemic stroke.

Authors:  Joseph F Arboleda-Velasquez; Zhipeng Zhou; Hwa Kyoung Shin; Angeliki Louvi; Hyung-Hwan Kim; Sean I Savitz; James K Liao; Salvatore Salomone; Cenk Ayata; Michael A Moskowitz; Spyros Artavanis-Tsakonas
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-17       Impact factor: 11.205

10.  Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides.

Authors:  Charlton Cooper; Jimin Guo; Yi Yan; Shilpa Chooniedass-Kothari; Florent Hube; Mohammad K Hamedani; Leigh C Murphy; Yvonne Myal; Etienne Leygue
Journal:  Nucleic Acids Res       Date:  2009-05-29       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.